Literature DB >> 6099391

Altered calcium handling as a cause of primary hypertension.

B F Robinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099391     DOI: 10.1097/00004872-198410000-00002

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  14 in total

Review 1.  The role of calcium supplementation in the treatment of hypertension. Current evidence.

Authors:  D E Grobbee; H J Waal-Manning
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

2.  Enhanced reactivity towards flunarizine in cerebrovascular bed of spontaneously hypertensive rats.

Authors:  E Koźniewska
Journal:  Experientia       Date:  1988-03-15

3.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

4.  Role of methylglyoxal in essential hypertension.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

Review 5.  [Analysis of forearm circulation--a substitute for diagnosis of coronary atherosclerosis?].

Authors:  G Rosenberger; S Fichtlscherer
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

6.  Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure.

Authors:  D E Grobbee; W H Hackeng; J C Birkenhäger; A Hofman
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

Review 7.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

8.  [Intracellular free calcium and plasma calcium in patients with essential hypertension. Is there a correlation between extracellular and intracellular disorders of calcium regulation in essential hypertension?].

Authors:  H Haller; T Philipp
Journal:  Klin Wochenschr       Date:  1988-05-16

Review 9.  Defective phosphoinositide metabolism in primary hypertension.

Authors:  A Remmal; S Koutouzov; A Girard; P Meyer; P Marche
Journal:  Experientia       Date:  1988-02-15

10.  Abnormality of calmodulin activity in hypertension. Evidence of the presence of an activator.

Authors:  S L Huang; Y I Wen; D B Kupranycz; S C Pang; G Schlager; P Hamet; J Tremblay
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.